apogenbiotech.com

ApoGen Biotechnologies

Breaking drug resistance in cancer, through the development of a new class of therapies, that target key drivers of ongoing DNA mutation and tumor evolution.
history traffic contact

OVERVIEW

The site apogenbiotech.com currently has a traffic classification of zero (the lower the better). We have downloaded eight pages within the site apogenbiotech.com and found nine websites referring to apogenbiotech.com. We have found one contacts and locations for apogenbiotech.com to help you contact them. The site apogenbiotech.com has been on the internet for seven hundred and thirty-eight weeks, twenty-eight days, ten hours, and forty-three minutes.
Pages Parsed
8
Links to this site
9
Contacts
1
Addresses
1
Online Since
Apr 2011

APOGENBIOTECH.COM TRAFFIC

The site apogenbiotech.com has seen variant levels of traffic within the past the year.
Traffic for apogenbiotech.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for apogenbiotech.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for apogenbiotech.com

Date Range

All time
This Year
Last Year
Last Month

APOGENBIOTECH.COM HISTORY

The site apogenbiotech.com was registered on April 29, 2011. This web page will expire on April 29, 2015. As of today, it is seven hundred and thirty-eight weeks, twenty-eight days, ten hours, and forty-three minutes young.
REGISTERED
April
2011
EXPIRED
April
2015

SITE AGE

14
YEARS
1
MONTHS
28
DAYS

LINKS TO APOGENBIOTECH.COM

Mayo Clinic Business Accelerator Rochester, Minnesota

Tax considerations for Start-up companies. Receive updates on news and events. Find out about the Mayo Clinic Business Accelerator and becoming a tenant. Access information on entrepreneurship, industry experts and forming a new company.

WHAT DOES APOGENBIOTECH.COM LOOK LIKE?

Desktop Screenshot of apogenbiotech.com Mobile Screenshot of apogenbiotech.com Tablet Screenshot of apogenbiotech.com

CONTACTS

Apogen Biotechnologies LLC

Dan Harki

1396 Canfield Ave

Saint Paul, Minnesota, 55108

United States

1.6129407424
info@apogenbiotech.com

APOGENBIOTECH.COM SERVER

We discovered that the main root page on apogenbiotech.com took two thousand seven hundred and nineteen milliseconds to load. We could not discover a SSL certificate, so therefore our web crawlers consider apogenbiotech.com not secure.
Load time
2.719 sec
SSL
NOT SECURE
IP
50.63.83.1

NAME SERVERS

ns1.bluehost.com
ns2.bluehost.com

FAVICON

SERVER SOFTWARE

We discovered that this website is weilding the Apache operating system.

SITE TITLE

ApoGen Biotechnologies

DESCRIPTION

Breaking drug resistance in cancer, through the development of a new class of therapies, that target key drivers of ongoing DNA mutation and tumor evolution.

PARSED CONTENT

The site apogenbiotech.com states the following, "Breaking drug resistance in cancer through the development of a new class of therapies that target key drivers of ongoing DNA mutation and tumor evolution." I noticed that the website stated " Accelerator Corporation Announces 7M Series A Investment in ApoGen Biotechnologies to Develop a New Class of Drugs Targeting Resistance to Cancer Therapy." They also stated " ApoGen Biotechnologies Raises 7 Million Series A. ApoGen Biotech Lands 7M to Take On Drug Resistance in Cancer."

SEE MORE WEBSITES

Apogenics, Inc.

Experienced advisors, providing advice and confidence. To make management better decisions. Apogenics solves the big challenges facing healthcare organizations. Starts with measuring what matters. Compliance and Regulatory advice for. 340B, Fair Market Value, and compliant.

Apogenix ǀ Immuno-oncology therapeutics for the treatment of cancer and other malignant diseases

Apogenix develops innovative immuno-oncology therapeutics for the treatment of cancer and other malignant diseases. The company has built a promising pipeline. Of drug candidates that target different TNFSF. Dependent signaling pathways, thereby restoring the anti-tumor immune response. Clinical Efficacy in Two Indications. The Apogenix team has created the HERA technology platform. For the development of novel he.

intrand randRANDMAX1.0; I was born in the wrong century for hats

This is awfully boring, I just want to PLAY. After the death of Emil Georg Bührle in 1956, the portrait was eventually given to the Foundation E. Bührle in Zurich where it is now on display. I have not been to see it in.

Auditorské, účetní a mzdové služby, daňové poradenství, znalecký ústav APOGEO

APOGEO je partnerem podnikohospodářské fakulty Vysoké školy ekonomické v Praze. Úzce spolupracujeme s 12 předními advokátními kancelářemi oceněné titulem Právnická firma roku. Služby APOGEO využilo již 11 ministerstev České republiky. Již 20 našich klientů patří dlouhodobě do TOP 100 českých firem. APOGEO je zakládajícím členem Asociace pro podporu a rozvoj svěřenských fondů. CZECH TOP 100 GOLF TROPHY 2018 presented by APOGEO.